Healthcare / Pharmaceutical RetailersUpdated 2026-05-10 22:07 UTC

BVMF/PGMN3 stock hub

BVMF/PGMN3 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/PGMN3is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.4B

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/PGMN3

In the news

Latest news · BVMF/PGMN3

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E8.8

P25 n/aP50 n/aP75 n/a

Trailing P/E10.9

P25 n/aP50 n/aP75 n/a

ROE10.1

P25 n/aP50 n/aP75 n/a

ROIC13.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/PGMN3 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

208

Groups with data

Currency

BRL

Showing 208 of 208 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Brazil
Country code	BR
Employees	28,207
Employees Change	2,150%
Employees Change Percent	8.25
Enterprise value	BRL 6.7B
Exchange	Brazil Stock Exchange
Financial currency	BRL
First seen	2026-05-10
Industry	Pharmaceutical Retailers
Isin	BRPGMNACNOR8
Last refreshed	2026-05-10
Market cap	BRL 3.4B
Price	BRL 5.1
Price currency	BRL
Rev Per Employee	543,966.67x
Sector	Healthcare
Sic	5912
Symbol	bvmf/PGMN3
Website	https://www.paguemenos.com.br

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	9.14%
EV Earnings	21.85x
EV/EBIT	7.36x
EV/EBITDA	4.74x
EV/FCF	-286.95x
EV/Sales	0.44x
FCF yield	-0.7%
Forward P/E	8.82x
P/B ratio	1x
P/E ratio	10.94x
P/S ratio	0.22x
PE Ratio3 Y	86.24x
PE Ratio5 Y	65.96x
PEG ratio	0.22x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	5.9%
EBITDA Margin	7.02%
Gross margin	32.21%
Gross Profit	BRL 4.9B
Gross Profit Growth	18.7%
Gross Profit Growth Q	17.21%
Gross Profit Growth3 Y	16.29%
Gross Profit Growth5 Y	17.76%
Net Income	BRL 307.5M
Net Income Growth	112.17%
Net Income Growth Q	950.82%
Net Income Growth Quarters	5%
Net Income Growth Years	2%
Net Income Growth3 Y	20.13%
Net Income Growth5 Y	18.61%
Pretax Margin	1.45%
Profit Margin	2%
Profit Per Employee	BRL 10,903
Profitable Years	6
ROA	6.13
Roa5y	3.87
ROCE	13.8
ROE	10.12
Roe5y	6.59
ROIC	13.63
Roic5y	9.13

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	51.75%
Cagr3y	28.35%
Cagr5y	-8.86%
EPS Growth Quarters	5
EPS Growth Years	2
FCF Growth Q	-22.45%
OCF Growth	-60.36%
OCF Growth Q	4.44%
OCF Growth10 Y	-0.18%
OCF Growth3 Y	-3.84%
Revenue Growth	16.86x
Revenue Growth Q	12.97x
Revenue Growth Quarters	23x
Revenue Growth Years	16x
Revenue Growth3 Y	15.97x
Revenue Growth5 Y	17.09x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 1.66
Assets	BRL 9.8B
Cash	BRL 241.3M
Current Assets	BRL 5.6B
Current Liabilities	BRL 3.2B
Debt	BRL 3.6B
Debt EBITDA	BRL 2.54
Debt Equity	BRL 1.07
Debt FCF	BRL -153
Equity	BRL 3.4B
Interest Coverage	1.63
Liabilities	BRL 6.5B
Long Term Assets	BRL 4.2B
Long Term Liabilities	BRL 3.2B
Net Cash	BRL -3.3B
Net Cash By Market Cap	BRL -99.46
Net Debt EBITDA	BRL 3.11
Net Debt Equity	BRL 1
Tangible Book Value	BRL 3.2B
WACC	8.61

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.73
Inventory Turnover	3.09
Net Working Capital	BRL 2.5B
Quick ratio	0.53
Working Capital	BRL 2.4B
Working Capital Turnover	BRL 8.4

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	1.88%
Dividend Growth Years	3%
Dividend per share	BRL 0.26
Dividend Years	3
Dividend Yield	5.05%
Ex Div Date	2025-12-26
Last Dividend	BRL 0.22
Payout Frequency	Annual
Payout Ratio	63.57%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	51.71%
200-day SMA	5.13
3Y total return	111.47%
50-day SMA	6.01
50-day SMA vs 200-day SMA	50over200
5Y total return	-37.12%
All Time High	13.75
All Time High Change	-62.91%
All Time High Date	2021-09-14
All Time Low	2.16
All Time Low Change	136.11%
All Time Low Date	2024-06-18
ATR	0.25
Beta	0.09
Beta1y	-0.01
Beta2y	0.02
Ch YTD	-16.26
High	5.19
High52	7.62
High52 Date	2026-02-20
High52ch	-33.07%
Low	5.03
Low52	3.22
Low52 Date	2025-05-22
Low52ch	58.39%
Ma50ch	-15.13%
Price vs 200-day SMA	-0.62%
RSI	31.09
RSI Monthly	53.93
RSI Weekly	42.04
Sharpe ratio	1.21x
Sortino ratio	1.93
Total Return	5.05%
Tr YTD	-16.26
Tr1m	-9.41%
Tr1w	-5.38%
Tr3m	-19.3%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL 906M
Operating Income Growth	45.76
Operating Income Growth Q	37.86
Operating Income Growth3 Y	39.14
Operating Income Growth5 Y	20.82
Operating margin	5.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	117,540,215%
Net Borrowing	-61,950,000
Shares Insiders	62.59%
Shares Institutions	8.33%
Shares Out	659,608,088

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL -23.4M
Average Volume	5,275,565x
CAPEX	BRL -226.8M
Ch1m	-9.41
Ch1w	-5.38
Ch1y	45.71
Ch3m	-19.3
Ch3y	70
Ch5y	-51.66
Ch6m	20.85
Change	1.8%
Change From Open	0.99
Close	5.01
Days Gap	0.8
Depreciation Amortization	170,576,000
Dollar Volume	29,783,490
Earnings Date	2026-05-04
EBIT	BRL 906M
EBITDA	BRL 1.1B
F Score	6
FCF	BRL -23.4M
FCF EV Yield	-0.35x
FCF Per Share	BRL -0.04
Financing CF	204,035,000
Fiscal Year End	December
Founded	1,981
Income Tax	BRL -85.4M
Investing CF	-282,369,000
Is Primary Listing	1
Last Earnings Date	2026-05-04
Last Report Date	2026-03-31
Ma150	5.62
Ma150ch	-9.19%
Ma20	5.59
Ma20ch	-8.78%
Net CF	125,021,000
Open	5.05
P OCF Ratio	16.54
Payment Date	2026-02-02
Position In Range	43.75
Ppne	2,542,635,000
Price Date	2026-05-08
Price EBITDA	BRL 3.12
Ptbv Ratio	1.07
Relative Volume	1.08x
Revenue	15,343,668,000x
Tax By Revenue	-0.56x
Tr6m	25.82%
Volume	5,839,900

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BVMF/PGMN3 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+5.1%

$0.26 annual per share

Payout ratio

+63.6%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

3 consecutive years of growth

Total shareholder yield

+5.1%

Next ex-dividend date: 2025-12-26

Performance

BVMF/PGMN3 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/PGMN3?

Insider, institutional, and short-interest positioning.

Institutional ownership

+8.3%

Share of float held by funds and institutions

Insider ownership

+62.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

BVMF/PGMN3 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

31.1

Neutral momentum band

Price vs 200-day MA

-0.6%

50/200-day relationship not available

Beta (5Y)

0.09

Less volatile than the market

Sharpe ratio

1.21

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/PGMN3

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/PGMN3 stock rating?

bvmf/PGMN3 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/PGMN3 analysis?

The full report lives at /stocks/bvmf/PGMN3/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/PGMN3?

The latest report frames bvmf/PGMN3 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/PGMN3 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.